Industry Veteran to Lead Park During More Than $100 Million Investment in New Attractions and Park Enhancements
CLICK HERE FOR HIGH-RES MEDIA ASSETS
, /PRNewswire/ -- Busch Gardens Tampa Bay today announced the appointment of Jon Vigue as the park's new President, ushering in a new era of growth and innovation at one of America's most iconic theme parks in the midst of a more than $100 million investment in new attractions and park enhancements.
Jon Vigue, a respected industry veteran with nearly 30 years of experience, joins Busch Gardens Tampa Bay as its new park president in the midst of a more than $100 million investment in new attractions and park enhancements. A respected attractions industry leader with nearly 30 years of experience, Vigue joins Busch Gardens Tampa Bay following his long-term tenure at Wild Adventures Theme Park in Georgia, where he led transformational operational strategies and development initiatives designed to elevate the guest experience and position the park for sustained growth.
His appointment comes at an exciting time for Busch Gardens Tampa Bay as it continues to make significant investments in new attractions, immersive animal experiences, and the guest experience, including food and beverage and entertainment offerings, all designed to enhance every visit from day to night. Recent major new additions include Wild Oasis, the immersive new family adventure area that debuted in 2025. Opening this year, the all-new Lion and Hyena Ridge represents the park's largest and most immersive animal habitat in more than a decade. The dynamic new realm features five young male lions and a pair of hyenas surrounded by expansive 270-degree viewing areas, water features and elevated rocky overlooks that bring guests closer than ever before.
"We are strategically focused on enhancing every aspect of the guest experience at Busch Gardens Tampa Bay and Jon's extensive industry experience makes him the ideal leader to help guide that vision forward," said Kyle Miller, Co-Chief Parks Operations Officer at United Parks & Resorts, Busch Gardens' parent company. "As we continue making meaningful investments across the park, we are confident Jon's leadership, operational excellence and passion for innovation will help drive our next chapter of growth."
Throughout his career, Vigue has built a strong reputation for operational leadership, team development and creating memorable guest experiences. Prior to Wild Adventures, he spent nearly two decades at Lake Compounce Theme Park, where he played a key role in the property's revitalization and long-term success. Beyond park operations, Vigue has been actively involved with the International Association of Amusement Parks and Attractions (IAAPA) since 2007, most recently serving as Chair of the Food & Beverage Committee for North America.
"I'm incredibly honored to join the talented team at Busch Gardens Tampa Bay and help lead one of the most iconic theme parks in the country," said Vigue. "The park has an extraordinary legacy of combining world-class thrills, inspiring animal experiences and immersive entertainment unlike anywhere else. I look forward to working alongside our passionate ambassadors as we continue building on that legacy, investing in the future and creating unforgettable experiences for guests and families across Tampa Bay and beyond."
The park's momentum continues this summer with significant new additions and expanded offerings. Guests can experience the return of the park's popular Summer Nights event, taking place through Aug. 9, featuring all-new entertainment, extended evening hours and spectacular nighttime productions. Highlights include the debut of the new Beach Bash show featuring retro-inspired music and high-energy performances, the return of fan-favorite Boom Box Dance Party and complimentary beer offerings for guests 21 and older. Indoor entertainment offerings including shows: Cirque Electric, Animal Tales, Icons and Rhythm of Nature, provide guests additional ways to stay cool while being entertained.
As night falls, Busch Gardens Tampa Bay's skyline transforms with the return of Wild Skies: Drone Show & Fireworks Spectacular. On select nights, guests can experience two all-new nighttime spectaculars featuring 400 synchronized drones, breathtaking fireworks and immersive music. The season begins with a patriotic production honoring America's 250th Birthday, followed by a new Busch Gardens-exclusive drone spectacular debuting July 10.
"I'm thrilled to be here and extremely excited about the future of Busch Gardens Tampa Bay," added Vigue. "I look forward to meeting our valued guests and annual passholders."
About Busch Gardens Tampa Bay
Busch Gardens® Tampa Bay is the ultimate family adventure, offering 300 acres of fascinating attractions based on exotic explorations around the world. Busch Gardens is a unique blend of thrilling rides, an AZA accredited zoo with over 16,000 animals representing more than 200 species, and exciting seasonal events all year providing unrivaled experiences for guests of every age. For more information, visit BuschGardensTampa.com. Busch Gardens is owned by United Parks & Resorts, Inc. (NYSE: PRKS), a leading theme park and entertainment company providing experiences that matter and inspiring guests to protect animals and the wild wonders of our world.
Christopher L. Finazzo, Chief Commercial Officer of United Parks & Resorts Inc. (PRKS +1.66%), disclosed the sale of 8,000 directly held common shares for a transaction value of approximately $294,000, according to a SEC Form 4 filing.
Transaction summaryMetricValueShares sold (direct)8,000Transaction value$294,000Post-transaction shares (direct)130,285Post-transaction value (direct ownership)~$4.79 millionTransaction value based on SEC Form 4 weighted average purchase price ($36.76); post-transaction value based on May 22, 2026 market close ($36.78).
Key questionsHow material was this sale in the context of Finazzo's holdings?
This transaction represented 5.79% of Finazzo's direct common stock position, a moderate reduction that leaves the executive with approximately $4.79 million in directly held common shares.Is this transaction consistent with Finazzo's recent insider activity?
Recent years show a pattern of periodic open-market sales by Finazzo, with this trade's size (~8,000 shares) falling below his historical maximums; the continuing reduction in trade size matches the declining share inventory after prior sales.Did the sale reflect any indirect or derivative interests?
No; all shares involved were held directly.What is the broader context for United Parks & Resorts Inc. at the time of this transaction?
As of May 22, 2026, the company's share price was $36.78 at market close, representing a 10.37% year-over-year increase.Company overviewMetricValuePrice (as of market close 5/22/26)$36.76Revenue (TTM)$1.65 billionNet income (TTM)$150.42 million1-year price change10.37%* 1-year price change calculated using May 22, 2026 as the reference date.
Company snapshotPRKS operates theme and water parks across the United States under brands including SeaWorld, Busch Gardens, Aquatica, Discovery Cove, Water Country USA, Adventure Island, and Sesame Place.The firm generates revenue primarily from park admissions, in-park spending (food, beverage, and merchandise), and ancillary services such as exclusive experiences and reservations-only attractions.It targets families, tourists, and group visitors seeking entertainment and leisure experiences in major U.S. travel destinations.United Parks & Resorts Inc. is a leading U.S. leisure and entertainment company with a diversified portfolio of theme and water parks. The company leverages well-known brands and strategic park locations across the United States, offering a diversified portfolio of leisure attractions. Its scale and operational history provide a competitive advantage in the consumer cyclical sector, positioning it as a prominent player in the domestic leisure market.
What this transaction means for investorsThis sale looks more like routine portfolio management than a warning sign. Finazzo has sold shares periodically in recent years, and this latest transaction still left him with a sizeable ownership position. Taken together, that is a far different signal than an executive making a wholesale exit.
The bigger story for investors is whether United Parks can translate improving guest spending into renewed attendance growth. First-quarter attendance fell 5% year over year to 3.2 million guests, contributing to a 3% revenue decline to $278.3 million and a net loss of $34.1 million. Adjusted EBITDA slipped 14% to $58 million.
Management argued the quarter was hurt by factors largely outside its control. CEO Marc Swanson said unfavorable weather reduced attendance by roughly 140,000 guests, while lower international visitation accounted for another 80,000 guests. Encouragingly, in-park spending reached a record $40.62 per guest and paid pass sales rose about 10% during the quarter.
The company is also putting capital behind its confidence, repurchasing roughly $157.5 million of stock through early May. For long-term investors, that may be more telling than a relatively modest insider sale. The key question is whether new attractions, stronger bookings, and growing season-pass demand can help attendance recover during the critical summer season.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool recommends United Parks & Resorts. The Motley Fool has a disclosure policy.
Archer Aviation (NYSE:ACHR | ACHR Price Prediction) has had a rough year. After running up above $14.62 in the last 52 weeks, the eVTOL hopeful now trades at $5.08, down 32.45% year to date.
Our 24/7 Wall St. price target for Archer Aviation is $11.51 over the next 12 months, implying 126.61% upside. The model rates Archer a buy with a moderate 50% confidence level, reflecting strong catalysts paired with real execution risk.
24/7 Wall St. Price Target Summary Metric Value Current Price $5.08 24/7 Wall St. Price Target $11.51 Upside 126.61% Recommendation BUY Confidence Level 50% A Brutal Six Months, But Catalysts Are Lining Up Archer has lost 22.09% in the past month and 56.69% over the trailing year. Q1 2026, filed May 11, 2026, showed EPS of -$0.28 against a -$0.24 consensus and a net loss of $217.7 million on just $1.60 million of revenue. Cash fell $188.8 million sequentially to $951.1 million.
CEO Adam Goldstein called it “another banner quarter”, pointing to “record FAA certification progress” and a strategy spanning air taxis, defense, and AI software. A June 26, 2026 shareholder vote on Texas reincorporation is the next governance milestone.
The Case for $14 and Higher The bull case rests on Archer becoming the first US eVTOL operator. They are the first eVTOL company to close Phase 3 of the FAA’s four-phase Type Certification process and the FAA has accepted 100% of 797 Means of Compliance.
Add the LA28 Olympics provider designation, partnerships with Korean Air (up to 100 aircraft), Japan Airlines, and Saudi PIF, plus a defense program with Anduril powered by NVIDIA’s IGX Thor and Palantir’s SMART AI work, and Archer becomes a multi-platform play.
The bull scenario points to $14.56, a 186.57% return. H.C. Wainwright carries a $18 Buy target. ARK holds 4.94% and BlackRock 6.9%, signaling institutional conviction.
What Could Go Wrong The bear thesis is straightforward: Archer burns cash at scale with almost no revenue. Q1 2026 R&D hit $171.7 million against $1.6 million of sales, and net losses widened 133.08% year over year. An $8 million vendor stock issuance in May highlighted dilution risk, and Goldman Sachs recently moved to Hold. The bear scenario projects $9.35, still above today’s price but well below the base target.
May 2026 insider sales by the CTO, CLO, Interim CFO, and Chief Accounting Officer were tax-driven, tied to RSU vesting. CEO Adam Goldstein received a 788,552 share deferred RSU grant with no sales.
Archer Aviation Price Prediction 2026-2030 The 24/7 Wall St. price target of $11.51 implies 126.61% upside and our model rates Archer a buy at 50% confidence. The key tipping factor is FAA Phase 4 progress paired with the LA28 contract and a defense pipeline the Street is not yet pricing in.
The bull case strengthens if Archer begins commercial US operations in the second half of 2026 as guided. The thesis weakens if Phase 4 slips into 2027 or if another dilutive raise lands before revenue scales.
Here is where our model projects Archer could trade, assuming certification holds and commercial revenue scales as planned.
Year 24/7 Wall St. Price Target 2026 $11.51 2027 $17.50 2028 $26.00 2029 $36.00 2030 $48.30 These projections assume Archer executes on FAA certification, scales Midnight production to 50 aircraft annually, and converts conditional international orders into revenue. Certification delays would drive significant downside, while defense award wins could accelerate the bull case.
Choosing between a high-growth electric aviation pioneer and a profitable defense manufacturer requires weighing long-term vision against financial stability. This is the trade-off between investing in Archer Aviation (ACHR +3.92%) or Karman (KRMN 3.19%) as the better stock to meet your goals.
Archer focuses on electric vertical takeoff and landing aircraft designed for urban travel. Karman provides critical systems for launch vehicles, satellites, and missile defense programs. While both operate within the aerospace landscape, they represent vastly different stages of corporate maturity and financial performance.
The case for Archer AviationArcher Aviation designs and develops Midnight, an electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. The company primarily targets the air taxi market, with plans to launch operations in the United States and the UAE. It maintains a conditional purchase agreement with United Airlines for up to $1.5 billion worth of aircraft. Customer concentration like this adds a layer of risk to the business, as a significant portion of its future relies on a single partner.
In its 2025 fiscal year (FY), revenue reached $300,000 as the company began its early commercial efforts. This resulted in a net loss of $618.2 million for the year. The net margin, which shows how much of each dollar of revenue remains after all expenses, was -206,067%.
As of its December 2025 balance sheet, the current ratio stands at 19.9x, indicating a strong ability to cover short-term debts with liquid assets. The debt-to-equity ratio, which compares total debt to the value owned by shareholders, is 0.1x. Free cash flow, calculated as cash from operations minus capital expenditures, was -$511.7 million.
The case for KarmanKarman designs and manufactures mission-critical systems used among defense stocks. It serves customers in launch vehicles, satellites, and missile defense, primarily within the United States. Its three largest customers accounted for 51.5% of total revenue in 2025. Customer concentration like this adds a layer of risk to the business, as losing one major partner would significantly impact financial results.
During FY 2025, revenue reached $471.5 million, representing growth of 36.6% over the previous year. The company reported net income of $17.4 million. The net margin was 3.7%, which reflects the percentage of revenue turned into profit after all costs.
As of its December 2025 balance sheet, the debt-to-equity ratio was 1.5x, meaning the company relies more on debt than equity to fund its assets. The current ratio, which measures the company's ability to pay short-term obligations, was 3.3x. Free cash flow for the period was -$42.5 million.
Risk profile comparisonArcher Aviation faces significant regulatory hurdles, as it must obtain FAA certification before it can begin commercial air taxi operations. The company currently generates very little revenue and expects ongoing losses, meaning it will likely need to raise more capital. It also faces competition from other developers like Joby Aviation. Any disruptions in its limited supply chain could lead to delays in aircraft production.
Karman faces risks from its heavy reliance on a few major customers, which create significant revenue concentration. It also depends on defense contracts from the U.S. government that can be terminated or reduced at any time. The company must navigate intense competition from larger aerospace firms such as Lockheed Martin. Furthermore, Karman must comply with strict cybersecurity requirements to remain eligible for future government projects.
Valuation comparisonArcher Aviation looks cheaper on a forward earnings basis, while Karman appears more attractive when comparing their price relative to total revenue.
MetricArcher AviationKarmanSector BenchmarkForward P/E58.1x84.4x29.8xP/S ratio12862.5x13.6xn/aSector benchmark uses the SPDR XLI sector ETF. Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
In comparing these two aerospace companies, Archer Aviation offers the potential for outsized share price gains in the future if its eVTOL vision can take flight commercially. It expects to begin initial operations in the U.S. this year.
Perhaps more significantly, Archer announced investments in defense and artificial intelligence that management believes can lead to substantial revenue opportunities. The company managed to boost sales to $1.6 million in the first quarter, and it ended Q1 with $1.8 billion in cash, cash equivalents, and short-term investments. This sum should help it fund operations as it ramps up sales.
Karman is the established company between this pair, and its business is booming. It reported record Q1 revenue of $151.2 million, up an impressive 51% year over year. Despite this, its stock fell near its 52-week low of $43.49 after Karman announced that it was selling more stock at $61 per share.
The drop in Karman’s stock price creates a buy opportunity. Its revenue is rising, and shares are well below their 52-week high of $118.38 reached in January. These factors make it the better buy in 2026.
Archer is a speculative stock with a lot of risk given its lack of sales. Perhaps it will someday be worth investing in, but right now, Karman is my pick.
You've probably heard of "friendly rivalries" in business, but there's nothing friendly about the rivalry between electric vertical takeoff and landing (eVTOL) aircraft makers Archer Aviation (ACHR +3.92%) and Joby Aviation (JOBY +6.50%).
The two aviation start-ups are fighting tooth and nail to be the first to gain commercial approval from the U.S. Federal Aviation Administration (FAA) to operate their eVTOLs as air taxis.
Recently, both companies filed lawsuits against one another alleging (among other things) corporate espionage, fraud, and secret ties to China.
A recent court ruling brought bad news for both companies, but Joby was still the clear winner (again). Here's what happened and how it might affect both companies' stocks.
Image source: Joby Aviation.
Claims and counterclaims It all started in November, when Joby filed a lawsuit against Archer and George Kivork, a former Joby employee who went to work for Archer. Joby alleged that Kivork brought stolen trade secrets to Archer and that Archer accidentally gave the game away when it approached a real estate developer who was one of Joby's strategic partners and revealed confidential details about the partner's exclusive agreement with Joby.
Archer vigorously denied the claims, and in March it hit Joby with a countersuit, alleging in part that Joby fraudulently imported components sourced from China, which were deliberately misclassified as other goods like socks to avoid U.S. tariffs and other oversight. The reference to socks had caused the countersuit to become known in aviation industry circles as "Sockgate."
Today's Change
(
3.92
%) $
0.21
Current Price
$
5.57
Joby, of course, denied all of the counterclaims, and on June 5 a judge finally weighed in.
One narrowed, one denied U.S. Magistrate Judge Susan van Keulen of the Northern District of California, who is hearing the case, dealt setbacks to both sides in her June 5 order.
She threw out several portions of Joby's suit, dismissing claims that pertained to trade secrets involving commercial strategy, regulatory planning, infrastructure planning, and technical aircraft information. Her reasoning was that Joby had not sufficiently explained how these materials had been misappropriated. She similarly dismissed a claim that Archer had induced Kivork to breach his agreement with Joby. However, Joby can amend these claims and resubmit them by June 22, which Joby plans to do.
Image source: Archer Aviation.
In good news for Joby, Van Keulen ruled that it had plausibly alleged Archer's misappropriation of confidential information related to the real estate developer's partnership. This was the core of Joby's suit against Archer, and the fact that it can move forward is good news for the company.
Even better for Joby, the judge dismissed all of Archer's counterclaims for fraud and import misclassification but gave Archer until June 29 to potentially refile an amended complaint. Archer's management has said it intends to do so.
How it affects investors The rulings represented a collective win for Joby, because it's always better to have your claims allowed than thrown out.
That said, Joby's remaining claims are comparatively minor. Even if proven, the penalty for having improper knowledge of a rival's contract with a real estate developer would be far less severe than the consequences of stealing a rival's technical aircraft information.
Today's Change
(
6.50
%) $
0.61
Current Price
$
10.00
Similarly, fraud and tariff evasion are no small matters, so Joby is likely breathing a sigh of relief... at least for now. Because both sides can refile, there's always the possibility that some of their amended claims will be allowed to proceed. We'll probably have to wait months before the judge rules on those updated claims, which might affect either company's share price.
Ultimately, investors should be more concerned with the companies' progress (or lack thereof) toward final FAA commercial approval of their eVTOL aircraft. Until they receive that approval (and possibly even afterwards), they'll remain very risky and speculative stocks. While a loss in court would likely have a small impact on either stock, failing to receive FAA approval would almost certainly tank their shares. Even "Sockgate" would pale in comparison.
East West Bancorp (EWBC - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for East West Bancorp is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
For East West Bancorp, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for East West BancorpThis bank holding company is expected to earn $10.61 per share for the fiscal year ending December 2026, which represents no year-over-year change.
Analysts have been steadily raising their estimates for East West Bancorp. Over the past three months, the Zacks Consensus Estimate for the company has increased 2.9%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of East West Bancorp to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at East West Bancorp (EWBC - Free Report) , a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. East West Bancorp currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if EWBC is a promising momentum pick, let's examine some Momentum Style elements to see if this bank holding company holds up.
A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.
For EWBC, shares are up 5.31% over the past week while the Zacks Banks - West industry is up 4.06% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 3.1% compares favorably with the industry's 2.62% performance as well.
Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Shares of East West Bancorp have increased 19.49% over the past quarter, and have gained 35.47% in the last year. In comparison, the S&P 500 has only moved 13.47% and 26.67%, respectively.
Investors should also take note of EWBC's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. Right now EWBC is averaging 929,892 shares for the last 20 days..
Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with EWBC.
Over the past two months, 9 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost EWBC's consensus estimate, increasing from $10.25 to $10.61 in the past 60 days. Looking at the next fiscal year, 8 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineTaking into account all of these elements, it should come as no surprise that EWBC is a #2 (Buy) stock with a Momentum Score of B. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep East West Bancorp on your short list.
Pennymac Selects AWS as Preferred Cloud Provider to Accelerate Generative AI Adoption, Deploy Conversational AI Across Lending Operations, and Position Plaisse for Commercialization
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--PennyMac Financial Services, Inc. (NYSE: PFSI) (Pennymac), one of America's leading U.S. mortgage lenders and servicers, is expanding its strategic agreement with Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), to accelerate its transformation into an AI-driven mortgage technology leader. Building on years of successful collaboration, Pennymac is now leveraging AWS’ generative AI capabilities to upgrade the mortgage application and servicing processes. As part of this digital transformation, the company has developed conversational AI-powered virtual assistant capabilities, powered by Amazon Nova Sonic, to elevate the borrower experience. Additionally, the expanded agreement accelerates the cloud modernization of Plaisse, Pennymac’s mortgage servicing platform, across its operations.
"Pennymac has spent 18 years building the operational scale and institutional knowledge to lead this industry — and now we're translating that into technology that fundamentally changes how mortgages are made,” said Jim Follette, Chief Digital Officer at Pennymac. “Our AI-driven virtual assistant and the continued modernization of Plaisse are the next stage of a deliberate, long-term strategy to deliver a superior, seamless journey for our borrowers. We chose AWS as our preferred cloud provider because they have the infrastructure to match our ambition. The future of mortgage technology is being built here, by Pennymac."
Pennymac’s digital modernization initiatives with AWS represent a comprehensive AI transformation strategy that moves past superficial integrations to transform the mortgage business. This corporate initiative is supported by substantial AWS engineering resources dedicated specifically to cloud-native, code-based optimization. The strategic alliance spans automated document processing, application upgrades, enhanced customer engagement, and data-driven decision-making capabilities.
With AWS, Pennymac is making it easier for borrowers to apply, understand their options, and get answers quickly by replacing fragmented legacy processes with an immediate, conversational borrowing experience. Architected around advanced speech-to-speech capabilities powered by Amazon Nova Sonic, Pennymac’s proprietary Natural Language Virtual Assistant (NLVA) delivers real-time voice interactions for phone contacts. Through Pennymac's intentional workflow engineering, the NLVA optimizes customer outreach by instantly engaging with users to identify new loan opportunities, deliver online application links, and schedule priority callbacks. This Pennymac-designed voice assistant provides around-the-clock responsiveness to handle after-hours calls and scale operations seamlessly, while human loan officers retain ultimate decision-making authority.
In addition to client-facing conversational AI, the agreement targets accelerated modernization of Plaisse software infrastructure. This collaborative technology advancement ensures the platform is designed to support the continuous enhancement of its industry-leading infrastructure to support institutional growth, continuous operational expediency, and seamless industry-wide distribution.
“Buying a home is one of the most important financial decisions a person will ever make, and for too long the process has felt like it was designed to slow people down,” said Beth Fatusin, Director, Worldwide Financial Services, AWS. “Pennymac is changing that. By building their AI-powered virtual assistant on AWS, they're giving borrowers a fast, clear, human-feeling experience at every step of the application. That's what it looks like when a financial institution puts customers first — and it's exactly the kind of transformation AWS was built to enable."
For over 18 years, Pennymac has established itself as a leading and respected mortgage lender and servicer, helping more than 5.6 million homeowners achieve their aspirations of homeownership. The company holds top national rankings as the #1 correspondent aggregator, #3 overall lender, and #3 wholesale lender. Pennymac's dedication to affordable lending and sustainable homeownership is one of the key drivers to its long-term growth and success. Pennymac's digital modernization initiatives with AWS encompass a comprehensive AI transformation strategy spanning automated document processing, application updates, enhanced customer engagement, data-driven decision-making capabilities, and the creation of next-generation mortgage servicing technology. For more information about Pennymac please visit PENNYMAC.COM.
About PennyMac Financial Services, Inc.
PennyMac Financial Services, Inc. is a specialty financial services firm focused on the production and servicing of U.S. mortgage loans and the management of investments related to the U.S. mortgage market. Founded in 2008, the company is recognized as a leader in the U.S. residential mortgage industry and employs approximately 5,300 people across the country. For the twelve months ended March 31, 2026, PFSI’s production of newly originated loans totaled $154 billion in UPB, making it a top lender in the nation. As of March 31, 2026, PFSI serviced loans totaling $720 billion in UPB, making it a top mortgage servicer in the nation. Additional information about PFSI is available at pfsi.pennymac.com.
About AWS
Amazon Web Services (AWS) is guided by customer obsession, pace of innovation, commitment to operational excellence, and long-term thinking. By democratizing technology for nearly two decades and making cloud computing and generative AI accessible to organizations of every size and industry, AWS has built one of the fastest-growing enterprise technology businesses in history. Millions of customers trust AWS to accelerate innovation, transform their businesses, and shape the future. With the most comprehensive AI capabilities and global infrastructure footprint, AWS empowers builders to turn big ideas into reality. Learn more at aws.amazon.com and follow @AWSNewsroom.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth's Most Customer-Centric Company, Earth's Best Employer, and Earth's Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding management’s beliefs, estimates, projections, and assumptions with respect to, among other things, the development and commercialization of our software, AI and other technologies, our future financial results, our future operations and business plans, as well as industry and market conditions, all of which are subject to change. Words like “believe,” “expect,” “anticipate,” “promise,” “project,” “plan,” and other expressions or words of similar meanings, as well as future or conditional verbs such as “will,” “would,” “should,” “could,” or “may” are generally intended to identify forward-looking statements. Actual results and operations for any future period may vary materially from those projected herein and from past results discussed herein. Factors which could cause actual results to differ materially from historical results or those anticipated include, but are not limited to: interest rate changes; changes in macroeconomic, consumer and real estate market conditions; changes in housing prices, housing sales and real estate values; rising homeownership costs negatively impacting housing affordability; the continually changing federal, state and local laws and regulations applicable to our highly regulated industry; lawsuits or governmental actions resulting from noncompliance with laws and regulations; the mortgage lending and servicing-related regulations promulgated by federal and state regulators and the enforcement of these regulations; licensing and operational requirements of jurisdictions applicable to our business, to which our bank competitors are not subject; changes to government modification programs; difficulties inherent in adjusting the size of our operations to reflect changes in business levels; purchase and sales opportunities for mortgage servicing rights; our substantial amount of indebtedness; increases in loan delinquencies, defaults and forbearances; foreclosure delays and changes in foreclosure practices; our dependence on U.S. government-sponsored entities and changes in their roles; our ability to manage third-party vendors and mortgage investor requirements; our exposure to counterparties that do not fulfill contractual obligations; our reliance on PennyMac Mortgage Investment Trust (NYSE: PMT) as a significant contributor to our mortgage banking business; maintaining sufficient capital and liquidity and compliance with financial covenants; our obligation to indemnify third-party purchasers or repurchase loans if loans that we originate, acquire, service or assist in the fulfillment of, fail to meet certain criteria; our obligation to indemnify PMT if our services fail to meet certain criteria or characteristics or under other circumstances; investment management and incentive fees; the accuracy or changes in the estimates we make about uncertainties, contingencies and asset and liability valuations; conflicts of interest in allocating our services and investment opportunities among us and our advised entity; our ability to mitigate cybersecurity risks, cyber incidents and technology disruptions; the development of artificial intelligence; the effect of public opinion on our reputation; our exposure to risks of loss and disruption in operations from severe weather events, man-made or other natural conditions, including climate change and pandemics; our ability to effectively identify, manage and hedge our credit, interest rate, prepayment, liquidity and climate risks; expansion of new business activities or strategies; our ability to detect misconduct and fraud; our ability to pay dividends to our stockholders; and our organizational structure and certain requirements in our charter documents. You should not place undue reliance on any forward- looking statement and should consider all of the uncertainties and risks described above, as well as those more fully discussed in reports and other documents filed by the Company with the Securities and Exchange Commission from time to time. The Company undertakes no obligation to publicly update or revise any forward-looking statements or any other information contained herein, and the statements made in this press release are current as of the date of this release only.
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PennyMac Financial Services, Inc. (NYSE:PFSI) for potential violations of the federal securities laws.
If you invested in PennyMac, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/pennymac-class-action-lawsuit.
Why is PennyMac Being Investigated for Violations of the Federal Securities Laws?
PennyMac originates and services home mortgages. Recently, PennyMac increased its capacity to originate loans to better retain borrowers seeking to refinance their mortgages—a process known as “recapture” —as interest rates declined. During the relevant period, PennyMac touted the success of its recapture efforts, representing to investors that its recapture rates were improving.
BFA is investigating whether PennyMac misrepresented its ability to recapture customers refinancing their mortgages as interest rates declined.
Why did PennyMac’s Stock Drop?
On January 29, 2026, PennyMac reported disappointing 4Q 2025 financial results. During PennyMac’s earnings call held the same day, PennyMac senior management revealed that although PennyMac had increased its origination capacity to recapture more refinance business, many competitors had also added capacity, creating a highly competitive origination environment that constrained PennyMac’s ability to take advantage of refinance opportunities. This news caused the price of PennyMac stock to decline more than 37%, from $140.70 per share at the close of trading on January 29, 2026, to as low as $93.50 per share on January 30, 2026.
Click here for more information: https://www.bfalaw.com/cases/pennymac-class-action-lawsuit.
What Can You Do?
If you invested in PennyMac, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public.
So What: If you purchased PennyMac securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=51887 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: On January 29, 2026, PennyMac filed a Current Report with the Securities Exchange Commission on Form 8-K announcing PennyMac's fourth quarter and full-year 2025 financial results. The report stated that PennyMac's "servicing segment pretax income was $37.3 million, down from $157.4 million in the prior quarter and $87.3 million in the fourth quarter of 2024," as well as "[retax income excluding valuation-related items was $47.8 million, down 70 percent from the prior quarter driven primarily by increased realization of mortgage servicing rights (MSR) cash flows as lower mortgage rates drove higher prepayment activity."
On this news, PennyMac's stock price fell $49.78 per share, or 33.3%, to close at $99.92 per share on January 30, 2026.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased PennyMac securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=51887 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On January 29, 2026, PennyMac filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing PennyMac's fourth quarter and full-year 2025 financial results. The report stated that PennyMac's "servicing segment pretax income was $37.3 million, down from $157.4 million in the prior quarter and $87.3 million in the fourth quarter of 2024," as well as "pretax income excluding valuation-related items was $47.8 million, down 70 percent from the prior quarter driven primarily by increased realization of mortgage servicing rights (MSR) cash flows as lower mortgage rates drove higher prepayment activity."
On this news, PennyMac's stock price fell $49.78 per share, or 33.3%, to close at $99.92 per share on January 30, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302160
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Sands logo The 2026 Sands Cares contribution is enabling The Center to provide paid work experience and transferable job skills to youth through its Espresso Yourself Cafe mobile coffee truck.
, /PRNewswire/ -- Las Vegas Sands (NYSE: LVS) today announced it has contributed $150,000 to The LGBTQ+ Center of Las Vegas (The Center) for a workforce training and employment program designed to support unhoused and housing-insecure youth through the organization's Espresso Yourself Café program.
Funding is enabling The Center to provide work experience and transferable job skills to 20 young adults ages 18-24 through development of the Espresso Yourself Café mobile coffee truck, which will provide them with pathways to sustainable employment, income stability and permanent housing.
The Center initially launched the Espresso Yourself Café as a permanent location in its main facility last year and has received strong participant engagement. The organization is extending the program to community locations through the mobile coffee truck while combining employment opportunities and job training for vulnerable youth.
"With Sands' continued and valued partnership, we are creating meaningful opportunities for vulnerable youth to build confidence, develop job skills and gain real-world work experience," said John Waldron, CEO of The Center. "This program reflects what The Center is all about – providing a safe and welcoming space where people can grow, thrive and reach their full potential."
Sands and The Center began working together through Sands Cares in 2021 when the company contributed to the expansion of the Arlene Cooper Community Health Center. Since then, Sands has continued Sands Cares investments that have enabled The Center to expand its health care resources, make improvements to its core facility and sustain its administrative office.
In addition, Sands hosted The Center in the Sands Cares Accelerator from 2023-2025, enabling the organization to expand and develop its marketing and communications capabilities through the exclusive three-year capacity-building program. Sands and The Center recently celebrated the nonprofit's Sands Cares Accelerator graduation and three-year accomplishments, which included increased media and social media visibility, recognition as a thought leader in community-based care and greater national awareness.
"We're entering a new phase in our work with The Center and embarking on an area that's very much aligned with our company's global focus on workforce development and providing economic empowerment through job skills and employment opportunities," Ron Reese, senior vice president of global communications and corporate affairs, said. "We've also been dedicated to the issue of youth homelessness in Las Vegas, so the opportunity to provide support for unhoused and housing-insecure youth was another strong connection with our priorities. We think this program will have great return for The Center and the youth who participate."
The Center has been a vital part of the Las Vegas Valley for 30 years and provides a safe, non-judgmental environment for life-enriching programs, wellness services, events, education and support for people who identify as LGBTQ+ and allies of the community. As the hub for an array of essential resources, The Center operates two clinics that deliver physical and mental health care, offers a variety of community service programs, and serves as a leading advocate for the LGBTQ+ community.
The Sands Cares partnership with The Center aligns with Sands' priorities on nonprofit partner advancement, workforce development, hardship relief and support for organizations serving diverse communities. To learn more about Sands Cares, visit sands.com/responsibility/communities/.
To learn more about The LGBTQ+ Center of Las Vegas, visit https://thecenterlv.org/.
About The LGBTQ+ Center of Las Vegas
For more than 30 years, The LGBTQ+ Center of Las Vegas has been providing a safe and welcoming place where everyone can receive the information, support, and services needed to thrive. With its headquarters located at 401 S. Maryland Parkway, The Center's threefold focus is to provide health services, advocacy, and community empowerment.
About Sands (NYSE: LVS)
Sands is the leading global developer and operator of integrated resorts. The company's iconic properties drive valuable leisure and business tourism and deliver significant economic benefits, sustained job creation, financial opportunities for local businesses and community investment to help make its host regions ideal places to live, work and visit.
Sands' portfolio of properties includes Marina Bay Sands® in Singapore and The Venetian® Macao, The Londoner Macao®, The Parisian® Macao, The Plaza® Macao and Four Seasons® Hotel Macao, and Sands® Macao in Macao SAR, China, through majority ownership in Sands China Ltd.
Dedicated to being a leader in corporate responsibility, Sands is anchored by the core tenets of serving people, communities and the planet. The company's ESG leadership has led to inclusion on the Dow Jones Best-in-Class Indices for World and North America, as well as Fortune's list of the World's Most Admired Companies. To learn more, visit www.sands.com.
Have you been paying attention to shares of Arrow Electronics (ARW - Free Report) ? Shares have been on the move with the stock up 10.9% over the past month. The stock hit a new 52-week high of $234.46 in the previous session. Arrow Electronics has gained 107.6% since the start of the year compared to the 18.2% gain for the Zacks Computer and Technology sector and the 69.8% return for the Zacks Electronics - Parts Distribution industry.
What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on May 7, 2026, Arrow Electronics reported EPS of $5.22 versus consensus estimate of $2.81 while it beat the consensus revenue estimate by 14.7%.
For the current fiscal year, Arrow Electronics is expected to post earnings of $19.15 per share on $37.06 in revenues. This represents a 73.77% change in EPS on a 20.11% change in revenues. For the next fiscal year, the company is expected to earn $19.91 per share on $38.21 in revenues. This represents a year-over-year change of 3.95% and 3.12%, respectively.
Valuation MetricsWhile Arrow Electronics has moved to its 52-week high over the past few weeks, investors need to be asking, what is next for the company? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Arrow Electronics has a Value Score of B. The stock's Growth and Momentum Scores are C and C, respectively, giving the company a VGM Score of B.
In terms of its value breakdown, the stock currently trades at 12X current fiscal year EPS estimates, which is not in-line with the peer industry average of 20.1X. On a trailing cash flow basis, the stock currently trades at 15.9X versus its peer group's average of 19.2X. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Zacks RankWe also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Arrow Electronics currently has a Zacks Rank of #1 (Strong Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Arrow Electronics passes the test. Thus, it seems as though Arrow Electronics shares could still be poised for more gains ahead.
INCHEON, South Korea & KIRKLAND, Quebec--(BUSINESS WIRE)--Organon and Samsung Bioepis expand agreement to commercialize PYZCHIVA® (ustekinumab), a biosimilar referencing STELARA® (ustekinumab) in Canada.
N-able offers exposure to cybersecurity and IT management. They sell their cybersecurity platform services through MSPs, VARs, and distributors. One of the aspects I like the most about NABL is its sticky subscription revenue base. Though management's guidance implies they'll need stronger execution in 2H2026. AI is the wildcard for this sector, and NABL is no exception. AI could strengthen NABL's platform, but it can also disrupt its services and the sector as a whole.
Iron Mountain (IRM +1.91%) works with some of the largest companies on the planet. More than 95% of Fortune 500 corporations and over 240,000 businesses count on Iron Mountain to store physical and digital assets.
Its data centers have gained momentum due to the artificial intelligence (AI) boom, and that's part of the reason the stock has more than doubled over the past five years. The rally doesn't appear to be over, as fundamentals remain strong.
Image source: Getty Images.
Iron Mountain has a customer list that is hard to beat Not only does Iron Mountain have a large customer base, but it has also been working with some of the top businesses for decades. Banks, governments, tech giants, and other companies have been customers for multiple decades.
Once customers start using Iron Mountain, they tend to stick around. The company has a 98% retention rate and gets to raise its prices as customers demand more physical and digital space. Iron Mountain's customers have the flexibility to pay more when needed, and that's made it easy for the real estate investment trust to deliver double-digit year-over-year revenue growth rates for several consecutive quarters, including Q1. Total sales were up by 21.6% year over year during that quarter.
Iron Mountain was recently named a 2026 Google Cloud Partner of the Year in the Business Applications category. That's a notable achievement since Alphabet is a long-term customer. Google's parent company will likely stick around, and the award suggests other cloud providers will continue to use Iron Mountain's service. Accolades like these can also attract new customers.
Revenue growth has been accelerating in recent quarters. The company delivered 16.6% year-over-year revenue growth in Q4 and 12.6% year-over-year growth in Q3. The growth rate is trending upward, and that has helped the stock beat the S&P 500 year to date.
Today's Change
(
1.91
%) $
2.39
Current Price
$
127.83
A solid yield is hard to find with this type of growth Iron Mountain's financial growth comes from a diversified group of customers. Rising AI spend also positions the company to accelerate revenue growth in future quarters. While Iron Mountain's service is a valuable component of the AI build-out, it's one of the few growth stocks that comes with a solid dividend yield.
The yield is nearly 3% right now, and the company raises its quarterly dividend at least once per year. It has hiked its dividend twice per year in some instances. The company's most recent dividend hike came in November 2025, when the quarterly dividend went from $0.785 per share to $0.864 per share, marking a 10% year-over-year increase.
A 10% dividend growth rate is one of the best indicators of a financially robust company that is still gaining market share. The high yield, impressive dividend growth rate, and star-studded customer pool make Iron Mountain worth closer consideration.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Iron Mountain (IRM - Free Report) Boston, MA-based Iron Mountain Incorporated provides records & information management services and data center space & solutions in many countries. The company began operating as a real estate investment trust (REIT) starting from the taxable year ended Dec. 31, 2014. This S&P 500 company serves more than 240,000 customers from various industries through several facilities.
IRM is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.
Momentum investors should take note of this Business Services stock. IRM has a Momentum Style Score of B, and shares are up 0.4% over the past four weeks.
Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.13 to $5.85 per share. IRM boasts an average earnings surprise of +3.3%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, IRM should be on investors' short list.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Werner Enterprises (WERN - Free Report) Werner Enterprises, Inc. is a transportation and logistics company founded in 1956. Headquartered in Omaha, NE, the company is primarily focused on transporting the truckload shipments such as retail store merchandise, consumer products, grocery products and manufactured products. The company operates mainly under two segments — Truckload Transporation Services (TTS) and Werner Logistics.
WERN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 45.75; value investors should take notice.
Four analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.10 to $0.94 per share. WERN also boasts an average earnings surprise of +30.6%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, WERN should be on investors' short list.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Werner Enterprises (WERN - Free Report) Werner Enterprises, Inc. is a transportation and logistics company founded in 1956. Headquartered in Omaha, NE, the company is primarily focused on transporting the truckload shipments such as retail store merchandise, consumer products, grocery products and manufactured products. The company operates mainly under two segments — Truckload Transporation Services (TTS) and Werner Logistics.
WERN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Transportation stock. WERN has a Momentum Style Score of B, and shares are up 2.2% over the past four weeks.
For fiscal 2026, four analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.10 to $0.94 per share. WERN boasts an average earnings surprise of +30.6%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, WERN should be on investors' short list.
MCLEAN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- TEGNA Inc. (NASDAQ: NXST) announced today that the Locked On Podcast Network is on track to reach one billion listens, views and social engagements by the end of 2026. Today marks the tenth anniversary of Locked On, the number one sports podcast network acquired by TEGNA in 2021.
Built on the idea that every fanbase deserves a daily, dedicated podcast and that hyper-local coverage could draw large audiences, Locked On evolved from a single show in 2016 into a network of 275 daily podcasts covering every NBA, NFL, MLB, and NHL team, and major college sports programs daily. Earning more than 90 million combined listens, views, and social engagements each month, the Locked On Podcast Network produces the most total episodes and has the largest podcast audience of any native sports network.
“Locked On’s founding principle, ‘Your Team. Every Day,’ has remained constant,” said David Locke, president, Locked On Podcast Network. “We fully committed to the idea that sports fans are fans of their team first and have never wavered from that belief. We have proven we can be successful delivering daily team-specific coverage for passionate fans. Across 275 shows and 10 uninterrupted years, that idea has held true.”
In recent years, the podcast network has continued to build momentum with a slate of new initiatives, including Postcasts and Squad Shows, FAST TV channels, programming in partnership with Amazon Fire TV, including Bracket Breakdown and College Football Kickoff, and rapid expansion across social channels which has generated millions of views. In addition, a new, free NBA Draft Guide will debut this week, to immerse fans more fully in the draft.
“Our first decade proved that sports fans want more depth, more insights, and more of the voices that share their deep commitment and loyalty to their teams,” said Carl Weinstein, chief operating officer, Locked On Podcast Network. “The next chapter is about delivering that in new ways. We’re excited to continue growing and engaging fans, wherever they are, with innovative coverage every day.”
About Locked On Podcast Network
Founded in 2016, Locked On produces more than 275 podcasts, providing in-depth coverage of every NBA, NFL, MLB, and NHL team, plus major college sports teams and conferences daily. The number one sports podcast network generates over 90 million listens, views, and social engagements each month. Its podcasts were streamed 515 million times in 2025 across the major podcast audio apps and for video on YouTube and leading OTT platforms.
About TEGNA
TEGNA Inc. is a wholly owned subsidiary of Nexstar Media Group, Inc. (NASDAQ: NXST), operating independently of Nexstar consistent with the “Hold Separate Order” issued by the United States District Court for the Eastern District of California on April 17, 2026. TEGNA is a multiplatform media company operating 64 local television stations in 51 U.S. markets, and hundreds of websites, mobile and Connected TV (CTV) apps, and Premion, a leading Connected TV and Over-the-Top (OTT) advertising platform.
For media inquiries, contact:
Molly McMahon
Director, Corporate Communications
703-873-6422 [email protected]
IRVING, Texas--(BUSINESS WIRE)--Nexstar Media Group, Inc. (NASDAQ: NXST) (“Nexstar” or “the Company”) announced that at its 2026 Annual Shareholders' Meeting shareholders voted to: Elect all nominees to Nexstar's Board of Directors; Affirm the executive compensation of the Company's Named Executive Officers; Ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026; and, Approve the 2026 Long-Term Omni.
June 18, 2026 16:30 ET | Source: Host Hotels & Resorts, L.P.
BETHESDA, Md., June 18, 2026 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, will report second quarter 2026 financial results on Wednesday, August 5, 2026, after the market close.
The Company will hold a conference call to discuss its second quarter 2026 results and business outlook on Thursday, August 6, 2026 at 10:00 a.m. ET. Conference call access information is as follows:
Conference Call:
USA/Canada Toll Free Number833-461-5787Conference ID509534202 A simultaneous webcast of the call will be available on the Company’s website at www.hosthotels.com.
A replay of the call will be available Thursday, August 6, 2026 until Wednesday, November 4, 2026 via webcast on the Company’s website.
ABOUT HOST HOTELS & RESORTS
Host Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real estate investment trust and one of the largest owners of luxury and upper-upscale hotels. The Company currently owns 71 properties in the United States and five properties internationally totaling approximately 41,700 rooms. The Company also holds non-controlling interests in seven domestic joint ventures.
I am upgrading Park Hotels & Resorts to a buy, driven by strong market momentum, property upgrades, and resilient top-line growth. PK demonstrates competitive positioning with a focus on upper-upscale renovations, notably achieving +27% group revenue growth at the Royal Palm South Beach. Despite volatile FFO and high leverage, PK offers a safe, elevated dividend yield (~6.8%) with solid coverage, though dividend growth is muted.
The FIFA World Cup 2026 is underway, and outside of the competition on the pitch, the competition for consumer dollars may be equally intense. Official estimates forecast U.S. accommodations and food services generating over $2.4 billion in incremental economic value from the tournament.
That number includes 21.3 million hotel room nights expected across the three host countries: the United States, Canada, and Mexico. On a granular level, FIFA and the World Trade Organization (WTO) have projected international travelers will stay an average of 12 days, attend roughly two matches each, and spend over $400 per day.
World Cup demand is one reason many hotel stocks have made a strong run this year. However, some of those stocks may present valuation concerns. A better option may be to look at full-service hotel REITs (real estate investment trusts) as direct, quantifiable beneficiaries.
Get Host Hotels & Resorts alerts:
Analysts have specifically flagged Host Hotels & Resorts (NASDAQ: HST), Park Hotels & Resorts NYSE: PK, and Ryman Hospitality Properties (NYSE: RHP) as having meaningful revenue exposure to World Cup markets. Each carries a different risk profile that may not be reflected in their respective stock charts.
Host Hotels & Resorts: The Momentum LeaderHost Hotels & Resorts has a concrete, named World Cup tie-in that the other companies on this list lack. Fairmont Mayakoba, one of its managed properties in Mexico, was officially selected to house national team delegations during the tournament. Management also specifically called out World Cup-related transient demand as a catalyst when it raised full-year 2026 guidance for comparable hotel RevPAR and EBITDAre earlier this year.
Host Hotels & Resorts Today
HST
Host Hotels & Resorts
$25.01 0.00 (0.00%)
As of 06/18/2026 04:00 PM Eastern
52-Week Range$15.11▼
$25.36Dividend Yield3.20%
P/E Ratio17.01
Price Target$23.95
HST is up 40% in 2026 and over 30% in the three months ending June 17. It’s also trading slightly above its consensus price target of $23.75. It’s fair to wonder if the biggest gains are priced in, especially with HST looking expensive by many conventional metrics.
HST has been in a steady, persistent uptrend since November, with price climbing from approximately $16 to nearly $25.
The 50-day SMA at $22.08 has been reliably ascending, and price has stayed above it cleanly. MACD is bullish with the line above the signal, but the histogram is narrowing slightly.
Of the three, HST's chart looks the most technically healthy—it's the momentum leader without a parabolic overshoot risk.
Park Hotels & Resorts: The High-Risk, High-Reward PlayPark Hotels & Resorts is a Hilton spinoff with a portfolio concentrated in urban markets, several of which are active World Cup host cities.
Park Hotels & Resorts Today
PK
Park Hotels & Resorts
$14.74 +0.03 (+0.17%)
As of 06/18/2026 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$9.84▼
$14.95Dividend Yield6.78%
Price Target$12.95
That direct city-level exposure is the core of the bull thesis here. The stock is up roughly 30% from its May lows and is trading well above its consensus price target of $12.68.
That means the World Cup tailwind may already be largely reflected in the price.
PK also has the most dramatic chart. The stock was essentially rangebound between $10–$12 for most of the past year, then exploded higher in late May/early June, nearly a 30% move in a matter of weeks.
The 50-day SMA at $11.93 is still ascending but hasn't caught up to price at $14.64 at all, which shows how vertical that move was.
MACD is sharply positive, but the histogram is already starting to shrink, which is worth watching. That kind of parabolic move often consolidates or pulls back before continuing.
Ryman Hospitality Properties: The Indirect Play With Real ExposureRather than broad urban hotel portfolios, Ryman Hospitality Partners owns the Gaylord Hotels brand. That means massive convention and entertainment resorts in markets including Nashville, Dallas, Denver, and Washington D.C.
Ryman Hospitality Properties Today
RHP
Ryman Hospitality Properties
$125.26 +0.12 (+0.09%)
As of 06/18/2026 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$83.82▼
$126.27Dividend Yield3.83%
P/E Ratio33.05
Price Target$122.27
Its Gaylord Texan property sits in the Dallas market, which is hosting a World Cup semifinal. Dallas is one of the highest-demand World Cup markets in the country. RHP carries a consensus Buy rating, though at $123; it is trading above its consensus price target around $122.
RHP has the cleanest uptrend of the three. Price has been steadily climbing since its April low near $95, now at $123 and well above the 50-day SMA at $109. The MACD is still bullish (line above signal), but the histogram bars are flattening, which suggests momentum is cooling after a strong run. Not a reversal signal yet, more of a "extended and catching its breath" setup.
Is It Too Late to Get in on This Trade?As noted above, each stock has made strong gains this year, and each is starting to show technical signals that momentum is slowing. But each company also shows consistency in revenue that isn’t event driven.
That fits with recent data from Accio that shows Baby Boomers and the wealthiest U.S. households are not planning to cut back on travel and entertainment spending and, in some cases, are expected to increase it, especially in luxury and experience-based segments, which fit nicely with the business model of these REITs.
For investors considering these names, the question is whether patient investors are better served waiting for a technical pullback toward the 50-day SMA on any of the three before adding exposure, rather than chasing extended moves that are already well ahead of analyst consensus.
Should You Invest $1,000 in Host Hotels & Resorts Right Now?Before you consider Host Hotels & Resorts, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Host Hotels & Resorts wasn't on the list.
While Host Hotels & Resorts currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Income hunters know Invesco KBW Premium Yield Equity REIT ETF (NASDAQ:KBWY) as one of the highest-yielding equity REIT funds on the market, with a 30-day SEC yield of 8.26% and a 12-month distribution rate of 8.6%. KBWY achieves that yield by weighting small and mid-cap REITs by dividend payout rather than market cap, loading the portfolio with rent rolls Wall Street tends to overlook. The question for KBWY holders is whether those rent checks can keep funding monthly distributions of roughly $0.12 per share when the 10-year Treasury sits near 4.5% and refinancing costs remain elevated.
How the rent roll feeds the distribution KBWY tracks the KBW Nasdaq Premium Yield Equity REIT Index, a yield-weighted basket of roughly 30 small and mid-cap REITs. Because REITs must distribute at least 90% of taxable income to maintain tax pass-through status, KBWY’s monthly payout is essentially pooled rent, lease, and mortgage income from underlying landlords. The fund charges a 0.35% expense ratio and manages roughly $291 million in assets, modest enough that distribution cuts at the top can move the needle.
The holdings doing the heavy lifting The top 10 names account for about 43% of assets, so their cash flows matter disproportionately. Three concentrate the safety question:
Innovative Industrial Properties (NYSE:IIPR), the cannabis-focused triple-net REIT, sits at about 6.4% of the fund. Tenant concentration in a still-federally-illegal industry has produced rent defaults that forced AFFO guidance lower in recent quarters. The dividend has been held flat, but coverage has thinned, and a single major tenant loss would hit KBWY’s distribution within a quarter. Community Healthcare Trust (NYSE:CHCT) is about 4.6% of assets. Medical-office leases are sticky, but CHCT’s payout ratio has run above 100% of FFO, meaning the dividend is funded partly by debt and ATM equity issuance rather than operating cash flow. That is the textbook setup for an eventual trim. SL Green Realty (NYSE:SLG | SLG Price Prediction) at about 4.2% represents the Manhattan office trade. Leasing momentum has improved, and management reset the dividend lower in 2023, so the current payout looks defensible. Valuation is the bigger concern than coverage here. Hotel exposure through Park Hotels & Resorts (NYSE:PK) adds operating leverage to RevPAR trends, fine in expansion but the first lever cut in a slowdown.
What the distribution history actually says KBWY’s monthly payout has held in a tight $0.1225 to $0.1253 band across every month of 2025 and into 2026. That stability is genuine, but it follows a long reset: distributions peaked near $0.21 in 2020 before stepping down as small-cap REITs cut payouts through the rate-hiking cycle. The bleeding has stopped. The cautionary note is that KBWY has historically tracked its underlyings down quickly when they cut.
Total return puts the yield in context Price-only performance has finally turned. KBWY is up 18% year-to-date and 23% over the past year, with shares around $17. Over five years the price is up just 14%, a reminder that the distribution has carried the total-return story and NAV is sensitive to long rates. With the 10-year near the top of its 12-month range and the 2s/10s spread compressing to 0.46%, refinancing risk for highly levered small-cap REITs remains the biggest swing factor.
The verdict on KBWY’s income KBWY’s distribution looks safe in the near term and fragile over a full cycle. Monthly payouts have been stable for over a year, top holdings are mostly covering their dividends, and the fund’s yield-weighted methodology automatically rotates out of names that cut. Holders should expect the headline yield to drift lower if rates stay elevated and one or two top holdings reset payouts, but a sudden distribution collapse would require a broader small-cap REIT credit event. Investors who want REIT-adjacent income with lower volatility and meaningful dividend growth, rather than the highest current yield, typically look outside the small-cap REIT universe entirely.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Kennametal (KMT - Free Report) Based in Latrobe, PA, Kennametal Inc. is a manufacturer, marketer and distributor of high-speed metal cutting tools, tooling systems and wear-resistant parts. Its products are marketed through a number of channels to the end users, comprising manufacturers of machine tools, transportation vehicles and various components, airframe, aerospace components, machinery (light and heavy), components (energy-related), and others. Also, the company’s products are used by manufacturers and suppliers in the oil and gas exploration, road construction, and other industries.
KMT is a #3 (Hold) on the Zacks Rank, with a VGM Score of B.
Momentum investors should take note of this Industrial Products stock. KMT has a Momentum Style Score of A, and shares are up 3.1% over the past four weeks.
For fiscal 2026, two analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.80 to $3.23 per share. KMT boasts an average earnings surprise of +18.6%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, KMT should be on investors' short list.
New York, New York--(Newsfile Corp. - June 16, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) breached their fiduciary duties to shareholders.
According to a federal securities lawsuit, Corcept Therapeutics Incorporated failed to disclose adverse facts concerning potential FDA approval of one of the Company's lead new product candidates, relacorilant, a medication being developed for multiple indications, including the treatment of hypercortisolism, or Cushing's syndrome. While the Company touted the expected success of FDA approval, it failed to disclose that the FDA had in fact expressed concerns to Corcept about the adequacy of the Company's clinical development program assessing relacorilant's effectiveness and that relacorilant's New Drug Application faced a material risk of rejection.
If you currently own CORT and purchased prior to October 31, 2024 please contact Justin Kuehn, Esq. by email at [email protected] or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for relacorilant as a treatment for patients with Cushing’s syndrome.
As requested by the FDA, the resubmission includes additional analyses of data included in the original NDA submission. Corcept expects the resubmission to receive a six-month review.
“We are pleased to return relacorilant’s NDA to the review process and look forward to working with the Agency to advance relacorilant toward approval as a treatment for patients with Cushing’s syndrome,” said Joseph K. Belanoff, M.D., Corcept’s Chief Executive Officer. “Relacorilant has the potential to benefit many patients and it’s important we make it available as quickly as possible. We appreciate the FDA’s ongoing engagement with our application.”
Corcept’s resubmission is based on positive data from its pivotal GRACE trial, the double-blind, placebo-controlled Phase III GRADIENT trial, relacorilant’s long-term extension study and earlier-stage development data. Corcept believes that these data show that relacorilant provides meaningful, durable improvements in the signs and symptoms of Cushing's syndrome, without causing some of the serious adverse events associated with currently approved medications – termination of pregnancy, hypokalemia, endometrial hypertrophy, vaginal bleeding, adrenal insufficiency and QT prolongation.
About Hypercortisolism (Cushing’s Syndrome)
Hypercortisolism, also known as Cushing’s syndrome, is caused by excessive activity of the hormone cortisol. Symptoms vary, but most patients experience one or more of the following manifestations: hypertension, central obesity, elevated blood sugar and difficult-to-control type 2 diabetes, severe fatigue and weak muscles. Irritability, anxiety, depression and cognitive disturbances are common. Hypercortisolism can affect every organ system and can be fatal if not treated effectively. Cardiovascular events are the most common cause of death among patients with hypercortisolism. Recent research shows that endogenous hypercortisolism is more prevalent than previously believed.
About Relacorilant
Relacorilant, an oral therapy, is a selective glucocorticoid receptor (GR) antagonist that modulates cortisol activity by binding to the GR but not to the body's other hormone receptors. Relacorilant is proprietary to Corcept and is protected by composition of matter, method of use and other patents. It has been designated an orphan drug by the FDA and the European Commission (EC) for the treatment of hypercortisolism and by the EC for the treatment of ovarian cancer. Under the brand name Lifyorli™, relacorilant was approved in combination with nab-paclitaxel for adults with platinum-resistant ovarian cancer by the FDA in 2026. Corcept has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for relacorilant to treat patients with platinum-resistant ovarian cancer.
About Corcept Therapeutics
For over 25 years, Corcept has focused on cortisol modulation and its potential to treat patients with a wide variety of serious disorders, leading to the discovery of more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. Corcept is conducting advanced clinical trials in patients with Cushing’s syndrome, solid tumors, ALS and liver disease. In 2012, the company introduced Korlym®, the first medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with endogenous Cushing’s syndrome, and in 2026, the company introduced Lifyorli™, approved in combination with nab-paclitaxel, the first FDA-approved selective glucocorticoid receptor antagonist for adults with platinum-resistant ovarian cancer. Corcept is headquartered in Redwood City, California. For more information, visit Corcept.com.
Forward-Looking Statements
Statements in this press release, other than statements of historical fact, are forward-looking statements based on our current plans and expectations and are subject to risks and uncertainties that might cause our actual results to differ materially from any future results expressed or implied by such forward-looking statements.
In this press release, forward-looking statements include statements concerning: Corcept’s resubmission of its NDA to the FDA for relacorilant as a treatment for patients with Cushing’s syndrome; Corcept’s expectation that this resubmission will receive a six-month review; Corcept’s intent to work with the FDA to advance relacorilant toward approval as a treatment for patients with Cushing’s syndrome; relacorilant’s potential to benefit many patients; and Corcept’s belief regarding the importance of making relacorilant available as quickly as possible.
A further description of risks and uncertainties can be found in our SEC filings, which are available at our website and the SEC’s website. These risks and uncertainties include, but are not limited to, those related to: our ability to operate our business; our efforts to study and develop Korlym, relacorilant, miricorilant, dazucorilant, nenocorilant and our other product candidates; those molecules’ clinical attributes; regulatory approvals, mandates, oversight and other requirements imposed on our products or our business by laws, regulations or discretion of government authorities; and the scope and protective power of our intellectual property. We disclaim any intention or duty to update forward-looking statements made in this press release.
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) breached their fiduciary duties to shareholders.
According to a federal securities lawsuit, Corcept Therapeutics Incorporated failed to disclose adverse facts concerning potential FDA approval of one of the Company’s lead new product candidates, relacorilant, a medication being developed for multiple indications, including the treatment of hypercortisolism, or Cushing’s syndrome. While the Company touted the expected success of FDA approval, it failed to disclose that the FDA had in fact expressed concerns to Corcept about the adequacy of the Company's clinical development program assessing relacorilant’s effectiveness and that relacorilant's New Drug Application faced a material risk of rejection.
If you currently own CORT and purchased prior to October 31, 2024 please contact Justin Kuehn, Esq. by email at [email protected] or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
Key Takeaways CORT resubmitted its NDA for relacorilant as a treatment for Cushing's syndrome.The resubmission includes additional analyses requested by the FDA from the original filing.Positive GRACE and phase III GRADIENT data and other studies supported the resubmitted application. Corcept Therapeutics (CORT - Free Report) announced that it has resubmitted the new drug application (NDA) for its proprietary, selective cortisol modulator, relacorilant, to the FDA as a treatment for patients with Cushing’s syndrome.
Corcept expects to receive a six-month review period for the resubmitted NDA for relacorilant in Cushing’s syndrome. The resubmission includes additional analyses of data from the original NDA submission, as requested by the FDA.
The resubmitted NDA was based on positive data from the GRACE study, the placebo-controlled phase III GRADIENT study, as well as long-term extension studies and earlier-stage development data.
Per management, the data from these studies demonstrate that relacorilant can provide meaningful and durable improvements in the signs and symptoms of Cushing’s syndrome, while avoiding some of the serious side effects associated with currently approved therapies.
CORT’s Price PerformanceYear to date, shares of Corcept have soared 134.9% against the industry’s decline of 9.1%.
Image Source: Zacks Investment Research
CORT’s Earlier Hurdle With Relacorilant in Cushing’s SyndromeIn December 2025, the FDA issued a complete response letter (“CRL”) to the NDA for relacorilant as a treatment of Cushing’s syndrome.
Following the issuance of the CRL, the FDA asked the company to conduct additional analyses of the NDA data.
In December 2024, the company submitted an NDA for relacorilant to the FDA for treating patients with hypercortisolism (Cushing's syndrome).
Relacorilant is a selective cortisol modulator that binds to the glucocorticoid receptor but not to the body's other hormone receptors.
A potential approval for relacorilant in Cushing's syndrome should help Corcept reduce the heavy dependence on its sole-marketed drug, Korlym, which is also approved for treating Cushing's syndrome.
CORT’s Relacorilant Approved in Ovarian CancerIn March 2026, the FDA approved Lifyorli (relacorilant) in combination with nab-paclitaxel for the treatment of adult patients with platinum-resistant ovarian cancer.
Corcept has also submitted a marketing authorization application to the European Medicines Agency, seeking approval for relacorilant plus nab-paclitaxel to treat patients with platinum-resistant ovarian cancer. A final decision in Europe is expected by the end of 2026.
The approval of Lifyorli is likely to help Corcept diversify its revenue base, given that the company’s top line was solely dependent on Korlym. The approval of Lifyorli should lower the company’s heavy dependence on Korlym for revenues. The company is likely to record Lifyorli sales from the second quarter of 2026.
CORT's Zacks Rank & Stocks to ConsiderCorcept currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the drug/biotech sector are Indivior Pharmaceuticals (INDV - Free Report) , Immunocore (IMCR - Free Report) and Liquidia Corporation (LQDA - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, estimates for Indivior Pharmaceuticals’ 2026 earnings per share have risen from $3.33 to $4.05, while estimates for 2027 have increased from $3.66 to $4.27 during the same time. INDV shares have risen 5.7% year to date.
Indivior Pharmaceuticals’ earnings beat estimates in each of the trailing four quarters, with the average surprise being 65.44%.
Over the past 60 days, estimates for Immunocore’s 2026 bottom line have improved from a loss of 88 cents per share to earnings of 6 cents. Over the same period, EPS estimates for 2027 have risen from 24 cents to 87 cents. IMCR stock has lost 17.7% year to date.
Immunocore’s earnings beat estimates in three of the trailing four quarters, while missing the same on the remaining occasion, with the average surprise being 46.66%.
Over the past 60 days, estimates for Liquidia’s 2026 earnings per share have risen from $1.50 to $2.97, while estimates for 2027 have increased from $2.91 to $4.81 during the same time. LQDA shares have surged 99.1% year to date.
Liquidia’s earnings beat estimates in three of the trailing four quarters, while missing the same on the remaining occasion, with the average surprise being 54.40%.
, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).
If you currently own shares of Manhattan Associates stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=35966 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected].
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
On June 17, 2026, Manhattan Associates Inc MANH shares experienced a decline of 5.3%, bringing the current price to $132.09. This move comes amid a challenging price performance, with the stock having ranged from a 52-week high of $247.22 to a low of $119.06 over the past year.
GF Value™ verdict: Current price of $132.09 is 49.8% below the GF Value™ estimate of $263.30, indicating significant undervaluation.GF Score™: 85/100, suggesting strong potential for long-term returns.Most notable signal: Insider activity shows that insiders sold $1.2M in the last 3 months, with no buying activity reported. Is MANH Overvalued or Undervalued? The current price of Manhattan Associates Inc MANH at $132.09 is significantly below the GF Value™ estimate of $263.30, which indicates that the stock is undervalued by approximately 49.8%. This significant margin of safety suggests an opportunity for investors who may be looking for undervalued assets in the software industry. The GF Valuation label categorizes the stock as "Significantly Undervalued," reinforcing the notion that there could be substantial upside potential if the stock price aligns more closely with its intrinsic value in the future.
However, while the undervaluation presents an opportunity, it is essential to consider potential risks, including market volatility and the possibility of continued declines in stock price. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates, and its current assessment reflects a favorable outlook for MANH.
How Does MANH's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 37.0x 74.0x Forward P/E 24.6x - Currently, Manhattan Associates Inc's P/E ratio stands at 37.0x, which is significantly below its 5-year median P/E of 74.0x. Additionally, the forward P/E of 24.6x suggests that the stock may be trading at a more favorable valuation compared to its historical averages. This P/E analysis aligns with the GF Value™ verdict, indicating that MANH is undervalued relative to its historical performance.
What Does MANH's GF Score™ Tell Us? Metric Rating GF Score™ 85/100 Financial Strength 6/10 Profitability 9/10 Growth 9/10 Valuation 4/10 Momentum 4/10 The GF Score™ of 85/100 indicates that Manhattan Associates Inc has strong fundamentals and is likely to deliver higher long-term returns compared to its peers. The highest scores in Profitability (9/10) and Growth (9/10) suggest that the company has robust earning potential and is effectively managing its resources. However, the lower scores in Valuation (4/10) and Momentum (4/10) highlight some challenges, particularly in maintaining a strong upward price trajectory in the current market environment.
What Are Insiders Doing with MANH Stock? Recent insider activity in Manhattan Associates Inc shows that insiders have sold $1.2 million worth of shares in the past three months, with no insider purchases reported. This selling trend may suggest a lack of confidence among insiders regarding the stock's near-term performance. While insider selling does not inherently indicate negative future performance, it does warrant attention from potential investors looking to gauge the sentiment of those closest to the company.
What This Means for Investors Based on the GF Value™ analysis, Manhattan Associates Inc appears to be undervalued at the current price of $132.09, with substantial upside potential if the market corrects towards its intrinsic value of $263.30. However, the challenges reflected in insider selling and lower momentum rankings should be carefully considered when evaluating the stock.
For the complete analysis, visit the Manhattan Associates Inc MANH stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is MANH's GF Score™?
MANH's GF Score™ is 85/100, indicating strong potential for long-term returns based on its financial health, profitability, and growth prospects.
Is MANH overvalued or undervalued?
MANH is currently undervalued, with a GF Value™ estimate of $263.30 compared to its current price of $132.09, suggesting significant upside potential.
What is MANH's P/E ratio?
MANH's P/E ratio is 37.0x, which is 50% below its 5-year median P/E of 74.0x, indicating it is trading at a more attractive valuation compared to its historical average.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
$1.4 billion-asset Louisiana bank plans to strengthen digital experience and operational resilience
, /PRNewswire/ -- Jack Henry® (Nasdaq: JKHY) announced today that First American Bank and Trust has selected Jack Henry's technology solutions to strengthen operations, enhance its digital banking experience, and support continued growth across Southeast Louisiana.
Founded in 1910 in Vacherie, Louisiana, First American Bank and Trust is a privately owned community bank with 25 locations. The bank serves retail and small business customers across Southeast Louisiana, with a strong foundation in residential lending and a growing focus on expanding its small business portfolio. The institution is deeply rooted in its local communities and known for its culture-driven approach to customer service.
To better meet evolving customer expectations and remain competitive with larger regional and national institutions, First American Bank and Trust selected Jack Henry's modern core processing platform. The bank will move from an in-house environment to a hosted model, improving efficiency while enhancing disaster recovery and resiliency – critical in a region frequently impacted by hurricanes.
The Banno Digital Platform™ will improve the bank's digital experience, giving customers greater visibility into their financial lives with tools such as credit scoring and enhanced financial insights. These capabilities are embedded into the platform to provide customers with better control of their finances. And, Tap2Local™ will support the bank's goal of growing its small business portfolio by providing it with a simple, integrated solution for accepting payments and streamlining accounting. The bank will further differentiate through Jack Henry's open ecosystem, which offers open integrations to more than 1,000 third-party fintechs.
"We were looking for a technology provider that can help us move forward while staying true to who we are as a community bank," said Ronnie Falgoust, President and CEO of First American Bank and Trust. "Jack Henry stood out for its strong reputation for customer support, ongoing investment in innovation, and open approach to technology. This will help us deliver better tools and experiences for our customers while supporting our plans to grow organically, particularly on the small business side."
Jack Henry's strategy of delivering modern service components in the public cloud was also a key factor for First American Bank and Trust. "You can see the pace of innovation in how their platform continues to evolve, making them stand out on the market," Falgoust added. "This ongoing development, combined with what we heard from peers, gave us confidence that we're making the right decision."
"First American Bank and Trust has built a strong legacy by continuing to evolve alongside its customers," said Jonathan Baltzell, President of Bank Solutions at Jack Henry. "With the right technology in place, the bank is well positioned to scale, innovate, compete, and deliver the experiences that make it the center of their accountholders' financial journeys."
About Jack Henry & Associates, Inc.®
Jack Henry® (Nasdaq: JKHY) is a well-rounded financial technology company that strengthens connections between financial institutions and the people and businesses they serve. We are an S&P 500 company that prioritizes openness, collaboration, and user centricity – offering banks and credit unions a vibrant ecosystem of internally developed modern capabilities as well as the ability to integrate with leading fintechs. For 50 years, Jack Henry has provided technology solutions to enable clients to innovate faster, strategically differentiate, and successfully compete while serving the evolving needs of their accountholders. We empower approximately 7,400 clients with people-inspired innovation, personal service, and insight-driven solutions that help reduce the barriers to financial health. Additional information is available at www.jackhenry.com.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Knight-Swift Transportation Holdings (KNX - Free Report) , which currently has a Momentum Style Score of B. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Knight-Swift Transportation Holdings currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if KNX is a promising momentum pick, let's examine some Momentum Style elements to see if this trucking company holds up.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.
For KNX, shares are up 3.78% over the past week while the Zacks Transportation - Truck industry is up 3.64% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 13.12% compares favorably with the industry's 13.2% performance as well.
Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Shares of Knight-Swift Transportation Holdings have increased 40.59% over the past quarter, and have gained 80.96% in the last year. On the other hand, the S&P 500 has only moved 12.48% and 26.22%, respectively.
Investors should also pay attention to KNX's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. KNX is currently averaging 4,221,084 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with KNX.
Over the past two months, 4 earnings estimates moved higher compared to 3 lower for the full year. These revisions helped boost KNX's consensus estimate, increasing from $1.93 to $1.97 in the past 60 days. Looking at the next fiscal year, 9 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineGiven these factors, it shouldn't be surprising that KNX is a #2 (Buy) stock and boasts a Momentum Score of B. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep Knight-Swift Transportation Holdings on your short list.
Investors with an interest in Transportation - Truck stocks have likely encountered both Knight-Swift Transportation Holdings (KNX) and Saia (SAIA). But which of these two stocks presents investors with the better value opportunity right now?
Knight-Swift Transportation (KNX +1.56%) is the largest full truckload carrier in the U.S., and it's always going to be at the center of the never-ending debate over where trucking companies are in the cycle. This week, the bears are winning the debate, with the stock declining by 11.4% through Friday morning, partly driven by a Citi analyst downgrading the stock to neutral from buy, even as the price target was raised to $90 from $72.
The cycle is turning Demand and pricing power in the trucking industry tend to be highly cyclical, with alternating periods of boom and bust. As ever, this leads investors to try to anticipate when inflection points will occur. The recent Citi downgrade reflects the idea that there's already "elevated optimism" in the stock, as the market has priced in a more positive trucking environment in 2026.
Today's Change
(
1.56
%) $
1.14
Current Price
$
74.15
Probably the best dataset to follow on trucking comes from Cass Information Systems, specifically its for-hire freight shipment data across North America. The Cass Freight Index (Shipments) has declined year over year every month since the start of 2023, but has been in positive territory month over month since February of this year. As such, the market is pricing in a return to year-over-year growth.
Image source: Getty Images.
Valuations still matter A quick look at Knight-Swift's enterprise value (market cap plus net debt) to earnings before interest, taxation, depreciation, and amortization (EBITDA) valuations suggests the analyst might have a point.
KNX EV to EBITDA data by YCharts
Ultimately, the debate will be settled by the strength of the trucking market recovery, but right now Knight-Swift looks priced for a strong recovery. If it doesn't occur, then the current valuation may look a little stretched.
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY) resulting from allegations that GoDaddy may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased GoDaddy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/godaddy-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: Rosen Law Firm is investigating potential civil securities claims.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY) resulting from allegations that GoDaddy may have issued materially misleading business information to the investing public.
So What: If you purchased GoDaddy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/cases/godaddy-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: Rosen Law Firm is investigating potential civil securities claims.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
Rosen Law Firm Encourages GoDaddy Inc. Investors to Inquire About Securities Class Action Investigation - GDDY PR Newswire
NEW YORK, June 18, 2026
, /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY) resulting from allegations that GoDaddy may have issued materially misleading business information to the investing public.
So What: If you purchased GoDaddy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
What to do next: To join the prospective class action, go to https://rosenlegal.com/cases/godaddy-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
What is this about: Rosen Law Firm is investigating potential civil securities claims.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-godaddy-inc-investors-to-inquire-about-securities-class-action-investigation--gddy-302803862.html
New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY) resulting from allegations that GoDaddy may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased GoDaddy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/godaddy-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: Rosen Law Firm is investigating potential civil securities claims.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302098
Almost every business owner with a website has heard of GoDaddy (GDDY +1.12%). It's the world's largest website registrar and generates annual recurring revenue from numerous businesses that keep their domain names. Companies only stop paying this expense when they're out of business, which makes GoDaddy's revenue predictable.
However, there is meaningful growth hidden behind the overall results, and a 35% year-to-date dip has turned the company into an underrated value stock.
Image source: Getty Images.
GoDaddy doesn't just make money with domains Domain registration is still a large part of GoDaddy's business. It brought in $768.7 million in the first quarter of 2026, making up 60.7% of total revenue. It was up by only 2.8% year over year, which partially explains why the stock trades at an 8.5 forward P/E ratio.
Today's Change
(
1.12
%) $
0.85
Current Price
$
76.96
However, there is a true growth engine hidden beneath the domains. GoDaddy has a segment called applications and commerce that makes up the remaining 39.3% of revenue. Some people use GoDaddy to create websites, store data, promote e-commerce product listings seamlessly, and design branding assets.
This part of the business grew by 11.6% year over year in Q1. It will gradually make up a higher percentage of total revenue, and it gives people who buy a GoDaddy domain more reasons to stick with the GoDaddy ecosystem.
GoDaddy is using AI to enhance its offerings The "applications and commerce" segment is already delivering respectable growth, but GoDaddy's AI investments can accelerate future gains for that part of the business. The company recently released the Airo AI Builder, which lets business owners design websites, e-commerce stores, and apps using AI prompts.
This tool saves business owners a lot of time, and it's already translating into revenue growth. GoDaddy told investors in its Q1 press release that the Airo AI Builder had "strong early adoption" and achieved a multimillion-dollar annualized bookings run rate within weeks of its beta launch.
GoDaddy's total revenue was $1.3 billion in Q1, which was a 6% year-over-year increase. This figure indicates that the Airo AI Builder still makes up a very small slice of total revenue. However, if momentum continues to build, it can start to influence overall sales.
The success also suggests that GoDaddy will continue to introduce new AI-enabled products and services. That can open up more revenue streams and ensure that the "applications and commerce" segment continues to exhibit double-digit year-over-year growth rates.
If the hottest part of the business continues to remain hot, the 8.5 forward P/E ratio looks like an absolute bargain. While some tech stocks continue to soar, leaving them vulnerable in the event of rising interest rates or broader corrections, GoDaddy offers steady growth and a greater margin of safety than most picks.
SPCX stock is climbing. See the chart and price action here. Gamma Squeeze Ahead? Experts expect high implied volatility from the start. Analysts at SpotGamma point out there is no positioning history, no IV anchor and no established gamma exposure profile — meaning options will price extreme uncertainty from day one.
Wide bid-ask spreads and rich premiums are the baseline expectation.
The structural setup is also notable: SPCX’s tradable float is just 3% to 5% of the company’s valuation, and that thinness matters enormously for options dealers.
If retail call-buying dominates early flow, dealers will likely be short gamma on a stock with almost no liquidity cushion — meaning their hedging activity amplifies price moves rather than dampening them.
The call-buying and dealer hedging could lead to a gamma squeeze — a rapid, often extreme surge in a stock’s price driven by the options market rather than the company’s underlying fundamentals.
It occurs when heavy buying of call options forces market makers to aggressively purchase the underlying stock to hedge their risk.
SpotGamma called the SpaceX setup “one of the highest-gamma-sensitivity environments of the decade.”
Zero Hedge also predicted a possible gamma squeeze that could drive the price to $400 per share.
"SPCX options start trading tomorrow: it could gamma squeeze to 400, surpassing NVDA," Zero Hegde wrote in a post on X.
Demand For SPCX Shares Is Sky-High Compounding the dynamic: an estimated $22 billion to $27 billion in forced mechanical index buying is expected from Nasdaq-100 and Russell trackers in the coming weeks, with SPCX’s Nasdaq-100 fast-entry expected 15 trading days post-IPO.
SpaceX is currently unprofitable, posting a net loss of $4.28 billion in Q1 2026 — making it the only publicly traded company over $1 trillion in market cap that isn’t generating profit. That hasn’t slowed demand.
"It has the TAM of a science fiction novel while the price to earnings-growth ratio of chips is the lowest it's been in the sector's history," Mike Purves, CEO of Tallbacken Capital Advisors, told CNBC.
"But there's a huge bid in upside calls for anything AI-related and that means the price for protection is higher too – I'd suggest SpaceX will be having that dynamic magnified."
Reuters reported that more than 115,000 options contracts on SpaceX were traded in the first ten minutes and 500,000 options contracts changed hands in the first hour, according to Trade Alert data.
The ExchangesFor exchanges, the moment is massive. Cboe and Nasdaq handled nearly 60% of all options volume last year, according to Bloomberg, and will host SPCX options.
Robinhood Markets Inc. (NASDAQ:HOOD), where options trading represents roughly a quarter of total revenue, could stand to benefit significantly.
SPCX Stock Price Activity: SpaceX stock was up 11.44% at $214.53 at the time of publication Tuesday, according to Benzinga Pro.
Photo: Dimitris Barletis / Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
, /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today unveiled its 2025 Corporate Responsibility Report.
Quest Diagnostics 2025 Corporate Responsibility Report Reach and Impact Statistics The theme of the report, At the Center of Healthcare, reflects Quest's connective role in healthcare as a provider of laboratory insights that empower more informed, proactive and personal care. The 2025 report details Quest's accomplishments over the last year and progress toward goals set in 2021 across the company's four strategic pillars of corporate responsibility: health access, employee and community engagement, governance and ethics, and environmental sustainability.
"Our care for the many communities we serve and live in shines through the actions we've taken to broaden healthcare access and improve our employee experience and environmental impact," said Jim Davis, Quest Diagnostics Chairman, CEO and President. "Over the past year, we made our services accessible and affordable for more patients and consumers, invested in our people, and strengthened our policies and systems in areas, such as medical quality and AI, that reflect Quest's deep focus on responsible business practice. These achievements demonstrate the passion and commitment of our nearly 57,000 employees and many collaborators across healthcare to working together to create a healthier world, one life at a time."
Report highlights:
Health access
Provided over one million discounted or donated testing requisitions to support lab testing access at a cost of more than $21 million to Quest. Through the Quest Diagnostics Foundation, invested in nonprofits and other organizations committed to improving access to healthcare, nutrition, and vital support services for underserved populations in Baltimore, Maryland, Paterson, New Jersey, and Chicago, Illinois. Employee and community engagement
Improved overall workforce retention by 2.1 percentage points compared to 2024 and achieved an Employee Engagement score 3 points above a healthcare industry benchmark. Welcomed over 2,500 employees to eleven employee business networks, surpassing 11,000 members. Governance and ethics
Added the new role of senior vice president and chief quality and regulatory affairs officer and strengthened global organizational quality and regulatory processes. Enhanced our AI and cybersecurity governance to promote responsible use of AI and bolster systems to address emerging security threats. Environmental sustainability
Achieved International Organization for Standardization (ISO) 14001:2015 certification for the environmental management systems at our laboratories in Lewisville, Texas and Marlborough, Massachusetts, reaching our goal to certify five labs by the end of 2025. Supported access to testing for individuals exposed to environmental health hazards, including firefighters affected by the 2025 Palisades fire in Los Angeles County and citizens in a Texas-designated cancer cluster. To read the full report, click on 2025 Corporate Responsibility Report.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com.
, /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its second quarter 2026 financial results on Thursday, July 23, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call.
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-388-5361 for domestic callers or 203-369-0416 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on July 23, 2026, until midnight Eastern Time on August 6, 2026.
Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors, and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
Published in Nature Communications, the new study finds that nearly 70% of a common bacterial strain that causes urinary tract infections, pneumonia and wound infections was non-susceptible to the three most used oral antibiotics
, /PRNewswire/ -- A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especially when it becomes multidrug-resistant and causes chronic urinary-tract infections (UTIs) in elderly women. But the extent of its effect on the broader population and its prevalence in the community was not well known – until now.
Klebsiella pneumoniae is a growing drug-resistance problem, according to a groundbreaking new study in the peer-reviewed Nature Communications by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI), part of Hackensack Meridian Health (HMH), and Quest Diagnostics (NYSE: DGX), one of the nation's leading providers of diagnostic information services.
More than 2,000 samples across 42 states were screened through the collaboration, as outlined in the paper entitled "Nationwide spread of multidrug resistant Klebsiella pneumoniae across U.S. communities." A total of 267 multidrug resistant sequence types were identified, the data finds.
"For a long time, highly resistant superbugs were primarily considered a problem for hospitals, but this study reveals a dangerous shift. These bacteria are spreading, and causing common infections that are resistant to the recommended antibiotics used to treat them," said co-author Meghan W. Starolis, MS, Ph.D., senior science director, Infectious Disease, Quest Diagnostics. "This research provides critical updates for public health, and, more importantly, it provides the genetic blueprint needed to start developing vaccines or other treatments for vulnerable patients."
Klebsiella pneumoniae is an overlooked threat. It not only causes urinary tract infections, pneumonia and wound infections, but also kills about 600,000 individuals annually worldwide, according to the World Health Organization. In the United States, it's the most common cause of hospital-acquired pneumonia. Worldwide, it's the second-leading cause of UTIs – and has shown itself to be especially prevalent in women of advanced age.
"Our work shows that there is a rapidly-evolving, plasmid-driven epidemic of community-associated multidrug resistant Klebsiella pneumoniae across the United States," said co-author Barry Kreiswirth, Ph.D., the veteran microbiologist at the CDI and professor of Medical Sciences at the Hackensack Meridian School of Medicine, who spearheaded the years-long project. "We need to continue surveillance of what these bacteria are doing, so we can detect, and ideally control, the emergence of the next high-risk clone."
Of the roughly 2,000 samples in the study, more than two-thirds were from female patients, and about three-quarters were from people older than 60. All told, 100 percent of the bacteria investigated were classified as multidrug resistant, and 69.5 percent were non-susceptible to the three most common oral antibiotics (fluoroquinolones, Bactrim and nitrofurantoin), "underscoring the urgent need for new oral treatment options." For patients who have these strains, the only option may be injectable antibiotics, said Kreiswirth.
The main culprit in this resistance spread is a gene known as CTX-M-15, which is easily swapped between different bacteria on plasmids (stray strands of DNA outside chromosomes). The gene has spread to hundreds of strains, bringing with it not only antibiotic-resistance traits but also tolerance for stress and metal exposure which has potentially enhanced its survival outside of human hosts, according to the findings.
The multidrug-resistant strains were previously identified mostly as a healthcare-associated pathogen. Beginning around 2007, however, studies started to identify an "expanding and under-recognized reservoir" of the culprit Extended-Spectrum Beta-Lactamase (ESBL) gene. The U.S. Centers for Disease Control and Prevention conducted a study finding a 53.3 percent increase in ESBL-producing bacteria between 2012 and 2017 – pointing toward community transmission.
The study by the CDI and Quest bridges that gap, the authors write. Geographical trends showed regional and statewide spread, and multi-state dissemination, "indicating widespread, underrecognized community reservoirs," according to the analysis.
Quest and CDI worked together to make this research possible. Using its nationwide network of microbiology labs, Quest Diagnostics provided CDI with deidentified culture isolates that were determined to be resistant to antibiotics for further sequencing by CDI, providing the researchers with a diverse sample set for analyzing.
"This is establishing a baseline," concluded Kreiswirth. "We need to keep looking at this to better understand the extent of the problem. But this is definite confirmation that there is a problem – and it needs to be addressed."
The study's strengths include its large scale and unique focus on everyday community infections rather than hospital cases; however, its limitation is the lack of detailed patient medical histories, making it difficult to know exactly where or how the patients originally contracted the infections.
"We are very proud to collaborate with the Center for Discovery and Innovation on this research," said Yuri Fesko, M.D., senior vice president and chief medical officer, Quest Diagnostics. "Relationships between commercial clinical labs and research organizations like CDI are so important to improving and informing public health."
Quest and Hackensack Meridian have a long-standing collaboration through which Quest provides reference laboratory testing and manages HMH's inpatient hospital labs. The study is the largest yet by researchers with the two NJ-based organizations.
ABOUT HACKENSACK MERIDIAN HEALTH
Hackensack Meridian Health brings together leading–edge care, research, and medical education to deliver the best outcomes, and care shaped around the unique needs of every patient we serve. By connecting prevention, specialty care, and life-saving discoveries, we improve every aspect of healthcare – from routine visits to the most advanced treatments, close to home and across the globe.
Home to New Jersey's first and only top 20 hospital in the nation according to U.S. News & World Report 2025-26, we ensure people can count on exceptional care today and benefit from the cures of tomorrow. Our not-for-profit network of 18 hospitals, 500+ care locations, and over 40,000 team members extend the horizon of health for all. And because medicine is never finished, we Keep Getting Better for every patient, family, and community who counts on us. Learn more at HackensackMeridianHealth.org and to donate visit GiveHMH.org.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Quest Diagnostics (DGX - Free Report) Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. provides diagnostic information services to a broad range of customers within its primary customer channels of physicians, hospitals, patients, and consumers. The company provides services to Independent Delivery Networks (IDN) throughout the United States, through its Professional Lab Services (PLS) offerings, which allow them to build and execute their laboratory strategy, improve quality, reduce healthcare costs, and focus on core competencies. The company is a key provider of reference testing for approximately half of the hospitals in the United States.
DGX is a #2 (Buy) on the Zacks Rank, with a VGM Score of B.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 18.45; value investors should take notice.
For fiscal 2026, 10 analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.11 to $10.72 per share. DGX boasts an average earnings surprise of +3.5%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, DGX should be on investors' short list.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Quest Diagnostics (DGX - Free Report) Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. provides diagnostic information services to a broad range of customers within its primary customer channels of physicians, hospitals, patients, and consumers. The company provides services to Independent Delivery Networks (IDN) throughout the United States, through its Professional Lab Services (PLS) offerings, which allow them to build and execute their laboratory strategy, improve quality, reduce healthcare costs, and focus on core competencies. The company is a key provider of reference testing for approximately half of the hospitals in the United States.
DGX is a #2 (Buy) on the Zacks Rank, with a VGM Score of B.
Momentum investors should take note of this Medical stock. DGX has a Momentum Style Score of B, and shares are up 0.6% over the past four weeks.
For fiscal 2026, 10 analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.11 to $10.72 per share. DGX boasts an average earnings surprise of +3.5%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, DGX should be on investors' short list.
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
One stock to keep an eye on is Churchill Downs (CHDN - Free Report) . CHDN is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock holds a P/E ratio of 14.21, while its industry has an average P/E of 24.02. Over the last 12 months, CHDN's Forward P/E has been as high as 22.77 and as low as 12.94, with a median of 16.51.
We also note that CHDN holds a PEG ratio of 1.63. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CHDN's industry has an average PEG of 1.64 right now. Over the past 52 weeks, CHDN's PEG has been as high as 3.70 and as low as 1.63, with a median of 2.57.
Investors should also recognize that CHDN has a P/B ratio of 6.42. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 9.22. Over the past 12 months, CHDN's P/B has been as high as 10.03 and as low as 5.93, with a median of 7.60.
Finally, investors should note that CHDN has a P/CF ratio of 10.49. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. CHDN's P/CF compares to its industry's average P/CF of 24.05. CHDN's P/CF has been as high as 18 and as low as 10.22, with a median of 13.14, all within the past year.
These are only a few of the key metrics included in Churchill Downs's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, CHDN looks like an impressive value stock at the moment.
Investors with an interest in Gaming stocks have likely encountered both Churchill Downs (CHDN - Free Report) and Take-Two Interactive (TTWO - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.
Churchill Downs has a Zacks Rank of #2 (Buy), while Take-Two Interactive has a Zacks Rank of #4 (Sell) right now. Investors should feel comfortable knowing that CHDN likely has seen a stronger improvement to its earnings outlook than TTWO has recently. However, value investors will care about much more than just this.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
CHDN currently has a forward P/E ratio of 12.28, while TTWO has a forward P/E of 34.27. We also note that CHDN has a PEG ratio of 0.59. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. TTWO currently has a PEG ratio of 3.43.
Another notable valuation metric for CHDN is its P/B ratio of 5.71. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, TTWO has a P/B of 12.13.
These metrics, and several others, help CHDN earn a Value grade of A, while TTWO has been given a Value grade of F.
CHDN sticks out from TTWO in both our Zacks Rank and Style Scores models, so value investors will likely feel that CHDN is the better option right now.